1 | mechanism | 13,456 |
2 | pathomechanism | 46 |
3 | cis-element | 10 |
4 | pseudocapacitance | 8 |
5 | harmlessness | 6 |
6 | hydrogelator | 3 |
7 | neuropathophysiology | 3 |
8 | phosphoglycoprotein | 3 |
9 | presupposition | 3 |
10 | asthenosphere | 2 |
11 | bearer | 2 |
12 | coadsorbent | 2 |
13 | compulsory-order | 2 |
14 | cost-per-tester | 2 |
15 | grant-in-aid | 2 |
16 | hsp70-promoter | 2 |
17 | knell | 2 |
18 | lysability | 2 |
19 | press-residue | 2 |
20 | shaper | 2 |
21 | timespan | 2 |
22 | 2-6°c | 1 |
23 | 2011.23 | 1 |
24 | aminotrialkoxides | 1 |
25 | approaches/ways | 1 |
26 | assett | 1 |
27 | cataractogenecity | 1 |
28 | chemolithotroph | 1 |
29 | complications.pa | 1 |
30 | conadministration | 1 |
31 | demotion | 1 |
32 | ear—that | 1 |
33 | efficacy.this | 1 |
34 | entropy-enthalpy-compensation | 1 |
35 | explainers | 1 |
36 | factor-structure | 1 |
37 | first-person-shooter-video-gamers | 1 |
38 | immunopotency | 1 |
39 | labilising | 1 |
40 | macro-microconcept | 1 |
41 | market-place | 1 |
42 | methods-causal | 1 |
43 | mono-esters | 1 |
44 | mrac | 1 |
45 | n-acylhydrazones | 1 |
46 | nano-antibody | 1 |
47 | near-eradication | 1 |
48 | phospho‑s326 | 1 |
49 | physico-chemistry | 1 |
50 | physiopathologies | 1 |
51 | point-estimation | 1 |
52 | presequences | 1 |
53 | psychotrauma | 1 |
54 | pten/akt/foxo | 1 |
55 | response.it | 1 |
56 | ros-scavenger | 1 |
57 | serious-but | 1 |
58 | sub-clades | 1 |
59 | tac-group | 1 |
60 | tensio-activity | 1 |
61 | turn- | 1 |
1 | 2-6°c | 1 |
2 | 2011.23 | 1 |
3 | aminotrialkoxides | 1 |
4 | approaches/ways | 1 |
5 | assett | 1 |
6 | asthenosphere | 2 |
7 | bearer | 2 |
8 | cataractogenecity | 1 |
9 | chemolithotroph | 1 |
10 | cis-element | 10 |
11 | coadsorbent | 2 |
12 | complications.pa | 1 |
13 | compulsory-order | 2 |
14 | conadministration | 1 |
15 | cost-per-tester | 2 |
16 | demotion | 1 |
17 | ear—that | 1 |
18 | efficacy.this | 1 |
19 | entropy-enthalpy-compensation | 1 |
20 | explainers | 1 |
21 | factor-structure | 1 |
22 | first-person-shooter-video-gamers | 1 |
23 | grant-in-aid | 2 |
24 | harmlessness | 6 |
25 | hsp70-promoter | 2 |
26 | hydrogelator | 3 |
27 | immunopotency | 1 |
28 | knell | 2 |
29 | labilising | 1 |
30 | lysability | 2 |
31 | macro-microconcept | 1 |
32 | market-place | 1 |
33 | mechanism | 13,456 |
34 | methods-causal | 1 |
35 | mono-esters | 1 |
36 | mrac | 1 |
37 | n-acylhydrazones | 1 |
38 | nano-antibody | 1 |
39 | near-eradication | 1 |
40 | neuropathophysiology | 3 |
41 | pathomechanism | 46 |
42 | phosphoglycoprotein | 3 |
43 | phospho‑s326 | 1 |
44 | physico-chemistry | 1 |
45 | physiopathologies | 1 |
46 | point-estimation | 1 |
47 | presequences | 1 |
48 | press-residue | 2 |
49 | presupposition | 3 |
50 | pseudocapacitance | 8 |
51 | psychotrauma | 1 |
52 | pten/akt/foxo | 1 |
53 | response.it | 1 |
54 | ros-scavenger | 1 |
55 | serious-but | 1 |
56 | shaper | 2 |
57 | sub-clades | 1 |
58 | tac-group | 1 |
59 | tensio-activity | 1 |
60 | timespan | 2 |
61 | turn- | 1 |
1 | turn- | 1 |
2 | 2011.23 | 1 |
3 | phospho‑s326 | 1 |
4 | psychotrauma | 1 |
5 | complications.pa | 1 |
6 | mrac | 1 |
7 | 2-6°c | 1 |
8 | grant-in-aid | 2 |
9 | market-place | 1 |
10 | pseudocapacitance | 8 |
11 | asthenosphere | 2 |
12 | factor-structure | 1 |
13 | press-residue | 2 |
14 | labilising | 1 |
15 | chemolithotroph | 1 |
16 | methods-causal | 1 |
17 | knell | 2 |
18 | mechanism | 13,456 |
19 | pathomechanism | 46 |
20 | timespan | 2 |
21 | phosphoglycoprotein | 3 |
22 | near-eradication | 1 |
23 | point-estimation | 1 |
24 | conadministration | 1 |
25 | entropy-enthalpy-compensation | 1 |
26 | presupposition | 3 |
27 | demotion | 1 |
28 | pten/akt/foxo | 1 |
29 | tac-group | 1 |
30 | compulsory-order | 2 |
31 | ros-scavenger | 1 |
32 | shaper | 2 |
33 | bearer | 2 |
34 | hsp70-promoter | 2 |
35 | cost-per-tester | 2 |
36 | hydrogelator | 3 |
37 | presequences | 1 |
38 | sub-clades | 1 |
39 | aminotrialkoxides | 1 |
40 | physiopathologies | 1 |
41 | n-acylhydrazones | 1 |
42 | efficacy.this | 1 |
43 | first-person-shooter-video-gamers | 1 |
44 | explainers | 1 |
45 | mono-esters | 1 |
46 | harmlessness | 6 |
47 | approaches/ways | 1 |
48 | ear—that | 1 |
49 | response.it | 1 |
50 | coadsorbent | 2 |
51 | cis-element | 10 |
52 | macro-microconcept | 1 |
53 | assett | 1 |
54 | serious-but | 1 |
55 | immunopotency | 1 |
56 | nano-antibody | 1 |
57 | neuropathophysiology | 3 |
58 | physico-chemistry | 1 |
59 | cataractogenecity | 1 |
60 | lysability | 2 |
61 | tensio-activity | 1 |